NCT00417573View on ClinicalTrials.gov

Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections

PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

December 31, 2006

Conditions

IgG DeficiencyInfections

Interventions

DRUG

IV Gamunex 10%

Trial Locations (1)

64111

Center for Rheumatic Disease, Allergy, Immunology, Kansas City

Sponsors

Collaborators (1)

Grifols Therapeutics LLC

All Listed Sponsors

collaborator

Grifols Therapeutics LLC

INDUSTRY

lead

The Center for Rheumatic Disease, Allergy, & Immunology

OTHER

NCT00417573 - Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections | Biotech Hunter | Biotech Hunter